Skip to main content
Deepti Anbarasan, MD, Psychiatry, New York, NY

DeeptiAnbarasanMDEpilepsy, neurology

Psychiatry New York, NY

Geriatric Psychiatry, Neuropsychiatry, Psychopharmacology, Clinical Pharmacology

Neuropsychiatrist, neurologist, epileptologist

Dr. Anbarasan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Anbarasan's full profile

Already have an account?

  • Office

    One Park Avenue, Room 8-313
    New York, NY 10016
    Phone+1 347-377-0959
    Fax+1 210-892-3629

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Clinical Neurophysiology, 2015 - 2016
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Psychiatry/Neurology, 2009 - 2015
  • New York University School of Medicine
    New York University School of MedicineClass of 2009

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2010 - 2026
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Epilepsy

Publications & Presentations

PubMed

Journal Articles

  • Laser Ablation Is Effective for Temporal Lobe Epilepsy with and Without Mesial Temporal Sclerosis if Hippocampal Seizure Onsets Are Localized by Stereoelectroencephalo...  
    Brett E Youngerman, Shraddha Srinivasan, Catherine A Schevon, Neil A Feldstein, Deepti Anbarasan, Hyunmi Choi, Carl W Bazil, Alison M Pack, Epilepsia

Press Mentions

  • How Do You Diagnose Adult A.D.H.D.?
    How Do You Diagnose Adult A.D.H.D.?November 19th, 2022
  • Narcolepsy Drug Might Be New Treatment Option for ADHD
    Narcolepsy Drug Might Be New Treatment Option for ADHDOctober 12th, 2023

Professional Memberships